[Analysis of Tat protein characteristics in human immunodeficiency virus type 1 sub-subtype A6 (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1)]. 2022

A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
D.I. Ivanovsky Institute of Virology FSBI «National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya» of the Ministry of Health of Russia.

Tat protein is a major factor of HIV (human immunodeficiency virus) transcription regulation and has other activities. Tat is characterized by high variability, with some amino acid substitutions, including subtypespecific ones, being able to influence on its functionality. HIV type 1 (HIV-1) sub-subtype A6 is the most widespread in Russia. Previous studies of the polymorphisms in structural regions of the A6 variant have shown numerous characteristic features; however, Tat polymorphism in A6 has not been studied.Goals and tasks. The main goal of the work was to analyze the characteristics of Tat protein in HIV-1 A6 variant, that is, to identify substitutions characteristic for A6 and A1 variants, as well as to compare the frequency of mutations in functionally significant domains in sub-subtype A6 and subtype B. The nucleotide sequences of HIV-1 sub-subtypes A6, A1, A2, A3, A4, subtype B and the reference nucleotide sequence were obtained from the Los Alamos international database. Q54H and Q60H were identified as characteristic substitutions. Essential differences in natural polymorphisms between sub-subtypes A6 and A1 have been demonstrated. In the CPP-region, there were detected mutations (R53K, Q54H, Q54P, R57G) which were more common in sub-subtype A6 than in subtype B. Tat protein of sub-subtype A6 have some characteristics that make it possible to reliably distinguish it from other HIV-1 variants. Mutations identified in the CPP region could potentially alter the activity of Tat. The data obtained could form the basis for the drugs and vaccines development.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054322 tat Gene Products, Human Immunodeficiency Virus Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV Transacting Transcription Protein,HIV tat Protein,Trans-Acting Transcription Factor, HIV,Trans Acting Transcription Factor, HIV,tat Protein, HIV

Related Publications

A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
January 2019, Voprosy virusologii,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
November 2020, Voprosy virusologii,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
September 2021, Voprosy virusologii,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
March 2004, Journal of virology,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
May 1995, Proceedings of the National Academy of Sciences of the United States of America,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
November 2004, Journal of virology,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
August 1997, Biochemical and biophysical research communications,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
July 1991, Journal of virology,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
November 2023, Viruses,
A I Kuznetsova, and K B Gromov, and D E Kireev, and A V Shlykova, and A E Lopatukhin, and E V Kazennova, and A V Lebedev, and A S Tumanov, and K V Kim, and M R Bobkova
January 1998, Neuroscience,
Copied contents to your clipboard!